%0 Journal Article %1 baldimmunecell %A Bald, T %A Landsberg, J %A Lopez-Ramos, D %A Renn, M %A Glodde, N %A Jansen, P %A Gaffal, E %A Steitz, J %A Tolba, R %A Kalinke, U %A Limmer, A %A Jonsson, G %A Holzel, M %A Tuting, T %D 2014 %E Discov, Cancer %J Cancer Discov %K kalinke %N 6 %P 674-687 %T Immune-cell poor melanomas benefit from PD-1 blockade after targeted type I IFN activation %V 4

@article{baldimmunecell, added-at = {2014-03-11T11:11:10.000+0100}, author = {Bald, T and Landsberg, J and Lopez-Ramos, D and Renn, M and Glodde, N and Jansen, P and Gaffal, E and Steitz, J and Tolba, R and Kalinke, U and Limmer, A and Jonsson, G and Holzel, M and Tuting, T}, biburl = {https://www.bibsonomy.org/bibtex/21842bc5290d3e6417e7b14bbdae6c14b/kalinke}, editor = {Discov, Cancer}, interhash = {7e28385eaaae65a508c6e8bbbfcbdaff}, intrahash = {1842bc5290d3e6417e7b14bbdae6c14b}, journal = {Cancer Discov}, keywords = {kalinke}, number = 6, pages = {674-687}, pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/24589924}, timestamp = {2014-06-24T09:27:43.000+0200}, title = {Immune-cell poor melanomas benefit from PD-1 blockade after targeted type I IFN activation}, volume = 4, year = 2014 }